President and Director 

Vice Presidents and Directors

  • William Norton, Co-founder of IFFGD, Milwaukee, WI 
  • Eleanor Cautley, Wisconsin Bureau of Health Information and Policy,
    Division of Public Health, Madison, WI 

Directors

  • Michael Cohen, Attorney-at-Law, Meissner Tierney Fisher & Nichols S.C., Milwaukee, WI 
  • Douglas Drossman, M.D., Drossman Gastroenterology, Chapel Hill, NC
  • Nancy Hartman, FACHE, Account Executive, Take Care Health Systems, Chicago, IL 
  • Emeran Mayer, M.D., Professor of Medicine, Physiology, and Psychiatry; Director, Center for Neurovisceral Sciences & Women's Health; and Co-director, CURE: Digestive Diseases Research Center, David Geffen School of Medicine at the University of California in Los Angeles, CA 
  • Richard Nelson, M.D., Consultant Surgeon, Department of Surgery, Northern General Hospital, Sheffield, South Yorkshire, UK
  • Jeannette Tries, Ph.D., Director of Therapy Services at Aurora Women's Pavilion of West Allis Memorial Hospital, West Allis, WI; Director of Biofeedback Services at the Continence Control Service, University of Illinois, Chicago, IL 
About IFFGD
Leadership
Nancy J. Norton, IFFGD President
Advisory Board
Board of Directors
Editorial Board Members
Our Mission
Awareness Activities & Accomplishments
Public Education & Awareness
Professional Education & Awareness
Year in Review
-2014
-2012/2013
Advocacy Activities
Legislative Successes
FGIMD Act (Functional Gastrointestinal and Motility Disorders Research Enhancement Act)
Congressional Testimony
FISCAL YEAR 2016
FISCAL YEAR 2013
FISCAL YEAR 2012
FISCAL YEAR 2010
FISCAL YEAR 2009
FISCAL YEAR 2008
FISCAL YEAR 2007
FISCAL YEAR 2006
FISCAL YEAR 2005
FISCAL YEAR 2004
FISCAL YEAR 2003
FDA and Other Testimony
Written Comments to FDA June 29, 2015
Oral Comments to FDA May 11, 2015
Comments to FDA July 16th, 2014
Written Comments to Noridian October 24, 2013
Testimony to FDA October 25, 2012
Testimony to FDA September 12, 2012
Testimony to FDA December 13, 2011
Testimony to FDA December 2, 2010
Testimony to FDA April 23, 2002
Comments to FDA November 9, 2000
Testimony to FDA June 27, 2000
Testimony to FDA June 26, 2000
Capital Hill Advocacy Day
Research
IFFGD Research Awards
IFFGD Symposium reports
2013 Professional Symposium
10th Symposium Report
10th Symposium Audio Recordings
More from the 10th Symposium on FGIDs
2011 Professional Symposium
9th Symposium Report
2009 Professional Symposium
2007 Professional Symposium
7th Symposium Report
2005 Professional Symposium
6th Symposium Report
2003 Professional Symposium
5th Symposium Report
2002 Conference - Advancing the Treatment of Incontinence
Funding
Corporate Support
Our Research Funding Needs
IFFGD Standards for Collaboration
Industry Council
Supporters
Code of Ethics
Contact Us
Media Contact
Donation

Our Mission

healthy family

Education and Research

Our mission is to inform, assist and support people affected by gastrointestinal (GI) disorders.

IFFGD works with patients, families, physicians, health care professionals, and others to broaden understanding about gastrointestinal disorders and support or encourage research.

Awareness Activities & Accomplishments

Advocacy Activities

IFFGD Research Award